If you have been diagnosed with MDS, you may be able to receive a stem cell transplant, also called a bone marrow transplant. It has the potential to cure MDS. Learn more about our stem cell ...

Thomas W. LeBlanc, MD, MA, discusses key clinical pearls for community oncologists in the treatment of anemia in patients ...

Request an Appointment Fred Hutch: A Leader in MDS Treatment Fred Hutch is recognized as a Center of Excellence by the Myelodysplastic Syndromes Foundation for the diagnosis and treatment of MDS. Our ...

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.

Several other diseases can be confused with MDS, including: aplastic anemia certain leukemias, including acute leukemia and large granular lymphocytic leukemia HIV infection an overactive immune ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

In this Spotlight review, we summarize the current understanding of the molecular machinery involved in epigenetic regulation, discuss how epigenetic alterations arise in MDS and contribute to its ...

Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.

Researchers of one abstract retrospectively analyzed data from over 2000 patients with MDS—either high risk or low risk—and found that IDH1-targeted treatment may yield improved outcomes for ...